This GENcast is part 2 of a 3-part series on Cas-CLOVER, “the proven alternative to CRISPR/Cas9,” sponsored by Demeetra AgBio. Demeetra has built extensive gene editing know-how, complementing its internally developed as well as globally sourced portfolio of intellectual property, which it transfers to its partners through simple commercial licenses with freedom to operate.

Jack Crawford, CEO of Demeetra, sat down with Dr. Molly Duman Scheel, professor in the department of medical and molecular genetics at the Indiana University School of Medicine – South Bend, and Dr. Corey Brizzee, director of gene editing at Demeetra.

The discussion focuses on the use of advanced gene editing technologies to create scalable, and eco-friendly biopesticides as described in the panelists’ latest publications in Journal of Fungi’s special issue “Development and Utilization of Yeast Resources” and Fermentation’s special issue “Advances in Yeast Biotechnology from Genomics to Industry.”

Podcast Guest:

Molly Duman Scheel
Molly Duman Scheel, PhD
Professor, Medical and Molecular Genetics
Indiana University School of Medicine – South Bend
Corey Brizzee
Corey Brizzee, PhD
Director of Gene Editing
Previous articleMoonwalk Biosciences Raises $57M to Edit the Epigenome
Next articleU.K. Boosts Presence at the Biologics Manufacturing Table